De Greef, chairman since 2008, was the Cambridge Heart’s CFO from 2005 to 2007. He’s also a principal partner with Taveyanne Capital Advisors. He previously sat on the boards for Endologix (NSDQ:ELGX) and BioLife Solutions Inc.
Neither departure involves a “disagreement with the company’s board of directors or its management,” according to a regulatory filing.
CAMH shares were trading at 0.6¢ apiece as of about 9:30 a.m. today.
Unilife names new president, elevates CEO to chairman
Unilife (NSDQ:UNIS) said it named Dr. Ramin Mojdeh as its president. Mojdeh will remain as the company’s COO. Unilife also named CEO Alan Shortall chairman of the board, succeeding Slavko James Joseph Bosnjak.
Vision-Sciences names CEO
Vision-Sciences (NSDQ:VSCI) promoted interim CEO Howard Zauberman to be its permanent chief executive and named him president and a member of the board. Zauberman was vice president of business development at Henry Schein (NSDQ:HSIC).
Cutera names marketing VP
Cutera (NSDQ:CUTR) appointed Jon Pearson as executive VP of marketing & clinical development. Pearson’s résumé includes stints at Lumenis and Syneron Medical Ltd. (NSDQ:ELOS).
Hill-Rom’s new CFO is Baxter vet
Hill-Rom Holdings (NYSE:HRC) hired James Saccaro as its CFO and senior vice president. Saccaro comes to the company after 11 years with Baxter (NYSE:BAX), where he most recently was vice president and global franchise head of specialty pharmaceuticals. Saccaro is slated to start Dec. 30.